| Income Statement | Dec2018 | Dec2019 | Dec2020 | Dec2022 | Dec2023 | Dec2024 | Dec2025 |
|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||
| Revenue (Quarter) | -46.92M | ||||||
| Operating items | |||||||
| Research & Development (Quarter) | 15.44M | ||||||
| Share-based Compensation (IS) (Quarter) | 3.09M | ||||||
| Selling, General & Administrative (Quarter) | 13.33M | ||||||
| Other Operating Expenses (Quarter) | -11.58M | ||||||
| Operating Expenses (Quarter) | 17.18M | ||||||
| Net income details | |||||||
| Profit After Tax (Quarter) | -1253.21M | ||||||
| Additional items | |||||||
| Shares Outstanding (Weighted Average) (Quarter) | 197.99M | 200.91M | 307.15M | 1,029.48M | 1.61M | 1.62M | 1.62M |
| Shares Outstanding (Diluted Average) (Quarter) | 161.34M | 162.17M | |||||
| Interest Expenses (Quarter) | 46.92M |